Amicus Therapeutics (FOLD) P/E Ratio
P/E Ratio as of Jul 3, 2025: -64.28
Average-62.51
Median-62.75
Minimum-65.96
Maximum-59.43
-64.28
Past Month+0.63 (0.97%)
The P/E ratio for Amicus Therapeutics (FOLD) is -64.28 as of Jul 3, 2025. This represents a increase of 69.07% compared to its 12-month average P/E ratio of -38.02. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Amicus Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Amicus Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Amicus Therapeutics to industry peers.
Amicus Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Amicus Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Amicus Therapeutics to industry peers.
Amicus Therapeutics (FOLD) P/E Ratio Insights
See Amicus Therapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Amicus Therapeutics (FOLD)
Order type
Buy in
Order amount
Est. shares
0 shares
Amicus Therapeutics (FOLD) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $5.84 | -61.54 |
| Jun 2, 2025 | $6.16 | -64.91 |
| May 1, 2025 | $6.68 | -36.25 |
| Apr 1, 2025 | $7.95 | -43.14 |
| Mar 3, 2025 | $9.13 | -49.54 |
| Feb 3, 2025 | $9.64 | -27.63 |
| Jan 2, 2025 | $9.31 | -26.68 |
Amicus Therapeutics (FOLD) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -64.28 | +138.07% |
| 2024 | -27.00 | +14.36% |
| 2023 | -23.61 | +78.32% |
| 2022 | -13.24 | +6.26% |
| 2021 | -12.46 | -42.31% |
| 2020 | -21.60 | — |
FAQs About Amicus Therapeutics (FOLD) P/E ratio
The latest P/E ratio of Amicus Therapeutics (FOLD) is -64.28, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Amicus Therapeutics’s last 12-month average P/E ratio is -38.02, compared to its current P/E ratio of -64.28. This reflects a increase of 69.07%.
Amicus Therapeutics’s current P/E ratio of -64.28 is higher than its last 12-month average P/E of -38.02. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Amicus Therapeutics’s average P/E ratio over the last 3 years is -24.78. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Amicus Therapeutics’s average P/E ratio over the last 5 years is -19.68. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.